A20 mRNA therapeutics ameliorate systemic sclerosis by suppressing TRAF-6/NF-KB signaling and DREAM expression and exerting antifibrotic effects. - Lee AR; Jeon SB; Kwak HW; Yang SW; Bang YJ; Lee SY; Lee SW; Park JH; Han SG; Choi JW; Park HJ; Cho ML; et al. (Frontiers in immunology, 2025)